Detalles de la búsqueda
1.
Similar HbA1c reduction and hypoglycaemia with variable- vs fixed-time dosing of basal insulin peglispro in type 1 diabetes: IMAGINE 7 study.
Diabetes Obes Metab
; 18 Suppl 2: 43-49, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27393722
2.
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.
Diabetes Obes Metab
; 18 Suppl 2: 50-58, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27723227
3.
Metabolic outcomes of matched patient populations initiating exenatide BID vs. insulin glargine in an ambulatory care setting.
Diabetes Obes Metab
; 14(7): 626-33, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22321776
4.
Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy.
Int J Clin Pract
; 66(12): 1147-57, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23061886
5.
The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study.
Diabetes Obes Metab
; 11(2): 118-22, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18518894
6.
All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Diabetes Obes Metab
; 11(2): 102-8, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18494803
7.
Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011.
J Diabetes Complications
; 30(2): 212-20, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689451
8.
Risk factors for 30-day readmission following hypoglycemia-related emergency room and inpatient admissions.
BMJ Open Diabetes Res Care
; 4(1): e000160, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27110366
9.
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.
Circulation
; 102(2): 157-65, 2000 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-10889125
10.
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.
Circulation
; 99(25): 3241-7, 1999 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-10385497
11.
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
Circulation
; 104(22): 2660-5, 2001 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-11723015
12.
Meal-stimulated C-peptide and insulin antibodies in type I diabetic subjects and their nondiabetic siblings characterized by HLA-DR antigens.
Diabetes
; 34(5): 440-5, 1985 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-3886461
13.
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
Diabetes
; 48(6): 1289-94, 1999 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-10342818
14.
Artifactual elevation of serum creatinine level due to fasting.
Arch Intern Med
; 144(8): 1575-6, 1984 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-6466015
15.
Influence of frequency, time interval from initial instruction, and method of instruction on performance competency for blood glucose monitoring.
Diabetes Care
; 13(5): 488-91, 1990 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-2351026
16.
Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.
Diabetes Care
; 23(11): 1648-53, 2000 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-11092287
17.
A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes.
Diabetes Care
; 18(7): 928-32, 1995 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-7555551
18.
Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide.
Diabetes Care
; 6(5): 488-92, 1983.
Artículo
en Inglés
| MEDLINE | ID: mdl-6400710
19.
Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients.
Diabetes Care
; 17(1): 20-9, 1994 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-8112185
20.
Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet, and corticosteroids.
J Clin Endocrinol Metab
; 56(1): 60-7, 1983 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-6336620